- Home
- VCTR vs PCVX Comparison
VCTR vs PCVX Comparison
Compare VCTR & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCTR
- PCVX
- Stock Information
- Founded
- VCTR 2013
- PCVX 2013
- Country
- VCTR United States
- PCVX United States
- Employees
- VCTR N/A
- PCVX N/A
- Industry
- VCTR Investment Managers
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- VCTR Finance
- PCVX Health Care
- Exchange
- VCTR Nasdaq
- PCVX Nasdaq
- Market Cap
- VCTR 3.9B
- PCVX 4.3B
- IPO Year
- VCTR 2018
- PCVX 2020
- Fundamental
- Price
- VCTR $60.07
- PCVX $31.45
- Analyst Decision
- VCTR Buy
- PCVX Strong Buy
- Analyst Count
- VCTR 10
- PCVX 10
- Target Price
- VCTR $68.80
- PCVX $136.50
- AVG Volume (30 Days)
- VCTR 287.1K
- PCVX 2.3M
- Earning Date
- VCTR 05-08-2025
- PCVX 05-07-2025
- Dividend Yield
- VCTR 2.81%
- PCVX N/A
- EPS Growth
- VCTR 40.38
- PCVX N/A
- EPS
- VCTR 4.38
- PCVX N/A
- Revenue
- VCTR $893,477,000.00
- PCVX N/A
- Revenue This Year
- VCTR $38.78
- PCVX N/A
- Revenue Next Year
- VCTR $15.08
- PCVX N/A
- P/E Ratio
- VCTR $13.70
- PCVX N/A
- Revenue Growth
- VCTR 8.82
- PCVX N/A
- 52 Week Low
- VCTR $43.82
- PCVX $27.66
- 52 Week High
- VCTR $73.42
- PCVX $121.06
- Technical
- Relative Strength Index (RSI)
- VCTR 57.00
- PCVX 37.17
- Support Level
- VCTR $58.01
- PCVX $28.09
- Resistance Level
- VCTR $60.00
- PCVX $36.71
- Average True Range (ATR)
- VCTR 1.93
- PCVX 2.47
- MACD
- VCTR 0.43
- PCVX 1.18
- Stochastic Oscillator
- VCTR 87.11
- PCVX 38.98
About VCTR Victory Capital Holdings Inc.
Victory Capital Holdings Inc is an independent investment management firm. The company operates its business through franchises and solutions platform. It provides centralized distribution, marketing, and operations infrastructure to the company's franchises and solutions platform. The company operates through one business segment that is Investment management services and products to institutional, intermediary, retirement platforms, and individual investors. The franchises and solutions platform manages a variety of investment strategies for its customers. It derives majority of its revenues from asset-based fees from investment management products and services to individuals and institutions.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.